[Mid-term analysis of prospective cohort study of rivaroxaban in preventing CRT in breast cancer].
Sang D, Fan SM, Li SY, Zhang JT, Wang HM, Zhao XH, Zheng LJ, Liang P, Xi GB, Zhao LM, Zhang YR, Yuan P.
Sang D, et al. Among authors: zhao xh, zhao lm.
Zhonghua Zhong Liu Za Zhi. 2024 Mar 23;46(3):256-262. doi: 10.3760/cma.j.cn112152-20231024-00218.
Zhonghua Zhong Liu Za Zhi. 2024.
PMID: 38494772
Chinese.